﻿<?xml version="1.0" encoding="utf-8"?>
<projects xmlns:pb="http://www.acdi-cida.gc.ca/opendata/pb/1-0-0">
  <header>
    <headerInformation>International Development Projects - 2026-06-12 5:12:22 PM - all published projects</headerInformation>
    <language>English</language>
    <filter></filter>
  </header>
  <project>
    <projectNumber>CA-3-P009758002</projectNumber>
    <dateModified>2026-06-12T06:33:05</dateModified>
    <title>Support to COVID-19 Therapeutics</title>
    <description>This project aims to advance equitable and affordable access to the most promising COVID-19 treatments in lower-income countries and lower-middle-income countries (LMICs). The project supports Unitaid in securing manufacturing capacity and supply for relevant treatments, including monoclonal antibodies, novel antivirals, and medical oxygen. This project contributes to the Access to COVID-19 Tools (ACT) -– Accelerator Therapeutics Partnership objectives. Project activities include: (1) increasing access to medical oxygen; (2) improving supply security across sub-Saharan Africa through market interventions; and (3) piloting the introduction, feasibility and acceptability of innovations in at least 5 countries.   This project represents additional funds provided to a pre-existing project in response to the COVID-19 pandemic. The description and expected results are the same.</description>
    <status>Closed</status>
    <start>2021-10-12T00:00:00</start>
    <end>2023-03-31T00:00:00</end>
    <countries />
    <executingAgencyPartner>WHO - World Health Organization </executingAgencyPartner>
    <DACSectors>
      <DACSectors>Infectious disease control 50.00%</DACSectors>
      <DACSectors>COVID-19 control 50.00%</DACSectors>
    </DACSectors>
    <maximumContribution>20000000.00</maximumContribution>
    <ContributingOrganization></ContributingOrganization>
    <expectedResults>The expected outcomes of the project include: (1) increased capacity of oxygen produced and delivered to low- and lower-middle income countries; (2) an expanded portfolio of fit-for-purpose new therapeutics adapted for low and middle income countries; and (3) ensured availability and affordability of therapeutics and a related package of care in low- and lower-middle income countries.</expectedResults>
    <resultsAchieved>Results achieved at the end of the project (March 2023) include: (1) expanded access to vital therapeutics for COVID-19 in low- and middle-income countries; (2) a 22% reduction in the price of medical liquid oxygen; and (3) provided support to more than 95 countries on oxygen needs assessments, surge planning, set up of national oxygen systems, and access to funding.</resultsAchieved>
    <aidType>Contributions to specific-purpose programmes and funds managed by implementing partners</aidType>
    <collaborationType>Bilateral</collaborationType>
    <financeType>Aid grant excluding debt reorganisation</financeType>
    <flowType></flowType>
    <reportingOrganisation>Global Affairs Canada</reportingOrganisation>
    <programName>YFMInternaAssistPartnershp&amp;Programing Br</programName>
    <selectionMechanism>Department-Initiated</selectionMechanism>
    <policyMarkers>
      <policyMarker level="1">Gender equality</policyMarker>
    </policyMarkers>
    <regions>
      <region>Africa, regional</region>
      <region>America, regional</region>
      <region>Asia, regional</region>
      <region>Oceania, regional</region>
      <region>Europe, regional</region>
    </regions>
    <alternameImPositions />
    <budgets>
      <budget budgetType="Original" startDate="2021-04-01T00:00:00" endDate="2022-03-31T00:00:00" valueDate="2021-10-12T00:00:00">20000000.00</budget>
    </budgets>
    <Locations />
    <otherIdentifiers>
      <otherIdentifier otherIdentifierType="CRS Activity identifier">2021200861</otherIdentifier>
    </otherIdentifiers>
    <participatingOrgs>
      <participatingOrg number="0001003693" city="Geneva 27                          " province="Geneva" countryCode="CH " channelCode="41143" iatiid="41143">WHO - World Health Organization </participatingOrg>
    </participatingOrgs>
    <programDataStructure />
    <relatedActivities>
      <relatedActivity relatedActivityType="Sibling">CA-3-P009758001</relatedActivity>
    </relatedActivities>
    <transactions>
      <transaction transactionDate="2021-10-12T00:00:00" valueDate="2021-10-12T00:00:00" transactionType="Commitment" flowType="ODA" tiedStatus="Untied">20000000.00</transaction>
      <transaction transactionDate="2022-01-25T00:00:00" valueDate="2022-01-25T00:00:00" transactionType="Disbursement" flowType="ODA" tiedStatus="">20000000.00</transaction>
    </transactions>
  </project>
</projects>